These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 2954723)

  • 1. Clinical application of atrial natriuretic polypeptide in patients with congestive heart failure: beneficial effects on left ventricular function.
    Saito Y; Nakao K; Nishimura K; Sugawara A; Okumura K; Obata K; Sonoda R; Ban T; Yasue H; Imura H
    Circulation; 1987 Jul; 76(1):115-24. PubMed ID: 2954723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natriuretic peptides in the treatment of heart failure.
    Yasue H; Yoshimura M
    J Card Fail; 1996 Dec; 2(4 Suppl):S277-85. PubMed ID: 8951590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between exogenous atrial natriuretic peptide and hemodynamics in dogs with congestive heart failure produced by experimental mitral regurgitation.
    Asano K; Masuda K; Okumura M; Kadosawa T; Fujinaga T
    J Vet Med Sci; 2001 Mar; 63(3):243-50. PubMed ID: 11307923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of therapeutic doses of human atrial natriuretic peptide on load and myocardial performance in patients with congestive heart failure.
    Mizuno O; Onishi K; Dohi K; Motoyasu M; Okinaka T; Ito M; Isaka N; Nakano T
    Am J Cardiol; 2001 Oct; 88(8):863-6. PubMed ID: 11676948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemodynamic, renal, and hormonal responses to brain natriuretic peptide infusion in patients with congestive heart failure.
    Yoshimura M; Yasue H; Morita E; Sakaino N; Jougasaki M; Kurose M; Mukoyama M; Saito Y; Nakao K; Imura H
    Circulation; 1991 Oct; 84(4):1581-8. PubMed ID: 1914098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Responses of plasma concentrations of A type natriuretic peptide and B type natriuretic peptide to alacepril, an angiotensin-converting enzyme inhibitor, in patients with congestive heart failure.
    Yoshimura M; Yasue H; Tanaka H; Kikuta K; Sumida H; Kato H; Jougasaki M; Nakao K
    Br Heart J; 1994 Dec; 72(6):528-33. PubMed ID: 7857734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The effects of atrial natriuretic peptide on left ventricular function in subjects with heart failure].
    Indolfi C; Piscione F; Volpe M; Lembo G; De Campora P; Russolillo E; Ambrosini V; Condorelli M; Chiariello M
    Cardiologia; 1991 May; 36(5):351-6. PubMed ID: 1836751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Acute changes in the hemodynamic profile and circulating levels of atrial natriuretic peptide induced by dobutamine in severe heart failure].
    La Vecchia L; Bottero M; Centofante P; Bedogni F; Ometto R; Cera A; Fortunato A
    G Ital Cardiol; 1996 Aug; 26(8):863-74. PubMed ID: 9005168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vessel dilator enhances sodium and water excretion and has beneficial hemodynamic effects in persons with congestive heart failure.
    Vesely DL; Dietz JR; Parks JR; Baig M; McCormick MT; Cintron G; Schocken DD
    Circulation; 1998 Jul; 98(4):323-9. PubMed ID: 9711937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiorenal and neurohumoral effects of endogenous atrial natriuretic peptide in dogs with severe congestive heart failure using a specific antagonist for guanylate cyclase-coupled receptors.
    Wada A; Tsutamoto T; Matsuda Y; Kinoshita M
    Circulation; 1994 May; 89(5):2232-40. PubMed ID: 7910118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of kaliuretic peptide on sodium and water excretion in persons with congestive heart failure.
    Nasser A; Dietz JR; Siddique M; Patel H; Khan N; Antwi EK; San Miguel GI; McCormick MT; Schocken DD; Vesely DL
    Am J Cardiol; 2001 Jul; 88(1):23-9. PubMed ID: 11423053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Haemodynamic effects of atrial peptide infusion in heart failure.
    Crozier IG; Nicholls MG; Ikram H; Espiner EA; Gomez HJ; Warner NJ
    Lancet; 1986 Nov; 2(8518):1242-5. PubMed ID: 2878131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of atrial natriuretic peptide on left ventricular performance in conscious dogs before and after pacing-induced heart failure.
    Ohte N; Cheng CP; Suzuki M; Little WC
    J Pharmacol Exp Ther; 1999 Nov; 291(2):589-95. PubMed ID: 10525076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atrial natriuretic peptide in congestive heart failure in the dog: plasma levels, cyclic guanosine monophosphate, ultrastructure of atrial myoendocrine cells, and hemodynamic, hormonal, and renal effects.
    Riegger GA; Elsner D; Kromer EP; Daffner C; Forssmann WG; Muders F; Pascher EW; Kochsiek K
    Circulation; 1988 Feb; 77(2):398-406. PubMed ID: 2962788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atrial natriuretic factor in normal subjects and heart failure patients. Plasma levels and renal, hormonal, and hemodynamic responses to peptide infusion.
    Cody RJ; Atlas SA; Laragh JH; Kubo SH; Covit AB; Ryman KS; Shaknovich A; Pondolfino K; Clark M; Camargo MJ
    J Clin Invest; 1986 Nov; 78(5):1362-74. PubMed ID: 2945832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Infusion of atrial natriuretic peptide to patients with congestive heart failure.
    Goy JJ; Waeber B; Nussberger J; Bidiville J; Biollaz J; Nicod P; Mooser V; Kappenberger L; Brunner HR
    J Cardiovasc Pharmacol; 1988; 12(5):562-70. PubMed ID: 2468056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis of atrial natriuretic polypeptide in human failing hearts. Evidence for altered processing of atrial natriuretic polypeptide precursor and augmented synthesis of beta-human ANP.
    Sugawara A; Nakao K; Morii N; Yamada T; Itoh H; Shiono S; Saito Y; Mukoyama M; Arai H; Nishimura K
    J Clin Invest; 1988 Jun; 81(6):1962-70. PubMed ID: 2968368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal and adrenal resistance against atrial natriuretic peptide in congestive heart failure: effect of angiotensin I-converting-enzyme inhibition.
    Wambach G; Schittenhelm U; Bönner G; Kaufmann W
    Cardiology; 1989; 76(6):418-27. PubMed ID: 2558792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rosiglitazone treatment restores renal responsiveness to atrial natriuretic peptide in rats with congestive heart failure.
    Goltsman I; Khoury EE; Aronson D; Nativ O; Feuerstein GZ; Winaver J; Abassi Z
    J Cell Mol Med; 2019 Jul; 23(7):4779-4794. PubMed ID: 31087547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term administration of atrial natriuretic peptide in patients with acute heart failure.
    Kitashiro S; Sugiura T; Takayama Y; Tsuka Y; Izuoka T; Tokunaga S; Iwasaka T
    J Cardiovasc Pharmacol; 1999 Jun; 33(6):948-52. PubMed ID: 10367599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.